Device
Transcutaneous spinal cord stimulator
Transcutaneous spinal cord stimulator is a medical device with 3 clinical trials. Currently 1 active trials ongoing.
Total Trials
3
Max Phase
—
Type
DEVICE
Molecule
—
Success Metrics
Completion Rate
0%(0/1)
Active Trials
1(33%)
Terminated
1(33%)
Phase Distribution
Ph not_applicable
3
100%
Phase Distribution
0
Early Stage
0
Mid Stage
0
Late Stage
Phase Distribution3 total trials
N/ANon-phased studies
3(100.0%)
Highest Phase Reached
UnknownTrial Status & Enrollment
Completion Rate
0.0%
0 of 2 finished
Non-Completion Rate
100.0%
2 ended early
Currently Active
1
trials recruiting
Total Trials
3
all time
Status Distribution
Active(1)
Terminated(2)
Detailed Status
Terminated1
Withdrawn1
Recruiting1
Development Timeline
Analytics
Development Status
Total Trials
3
Active
1
Success Rate
0.0%
Most Advanced
N/A
Trials by Phase
N/A3 (100.0%)
Trials by Status
terminated133%
withdrawn133%
recruiting133%
Recent Activity
1 active trials
Showing 3 of 3
recruitingnot_applicable
Spinal Cord Stimulation for Respiratory Rehabilitation in Patients With Chronic Spinal Cord Injury
NCT06019949
withdrawnnot_applicable
Transcutaneous and Epidural Stimulation in SCI
NCT04627441
terminatednot_applicable
Transcutaneous and Epidural Spinal Stimulation for Enabling Motor Function in Humans With Motor Complete Paraplegia
NCT03945331
Clinical Trials (3)
Showing 3 of 3 trials
NCT06019949Not Applicable
Spinal Cord Stimulation for Respiratory Rehabilitation in Patients With Chronic Spinal Cord Injury
NCT04627441Not Applicable
Transcutaneous and Epidural Stimulation in SCI
NCT03945331Not Applicable
Transcutaneous and Epidural Spinal Stimulation for Enabling Motor Function in Humans With Motor Complete Paraplegia
All 3 trials loaded
Drug Details
- Intervention Type
- DEVICE
- Total Trials
- 3